Anxiety starts with a communication breakdown between two key brain regions: the amygdala, which detects threats, and the prefrontal cortex, which tells the amygdala to stand down when a threat isn’t real. In an anxious brain, the prefrontal cortex loses its ability to quiet the amygdala, leaving the threat alarm stuck in the “on” position. But this circuit is only part of the story. Anxiety involves a web of chemical signals, stress hormones, structural brain differences, and even changes to how your genes are read.
The Amygdala and Prefrontal Cortex Tug-of-War
Your amygdala is a small, almond-shaped cluster deep in the brain that acts as a threat detector. When it senses danger, it fires off signals that trigger your heart to race, your muscles to tense, and your attention to narrow. Under normal conditions, the medial prefrontal cortex steps in like a supervisor, sending inhibitory signals that dial down the amygdala’s output once the threat has passed. This back-and-forth is what allows you to feel a flash of fear and then calm down when you realize everything is fine.
In anxiety disorders, this balance tips. Research in neural plasticity has shown that the prefrontal cortex reduces fear responses by directly decreasing the firing of neurons in the central amygdala. When that prefrontal brake weakens, whether from chronic stress, trauma, or other factors, the amygdala essentially takes control. Fear responses that should fade away instead persist. This is why someone with anxiety can recognize that a situation isn’t dangerous yet still feel overwhelming dread. The logical part of the brain simply can’t overpower the emotional alarm system.
Brain imaging studies of people with PTSD illustrate this vividly. Their scans consistently show an overactive amygdala paired with reduced prefrontal cortex activity, a pattern researchers describe as a failure of “top-down” inhibition. The same dynamic appears across generalized anxiety disorder and other anxiety conditions, though the severity varies.
A Separate Region Drives Lingering Worry
The amygdala is best understood as a fast-response system. It reacts to specific, immediate cues: a loud noise, a face that looks threatening, a sudden shadow. But anxiety often isn’t about a specific trigger. It’s a diffuse, lingering unease that hangs around for hours or days. That sustained feeling involves a different brain structure called the bed nucleus of the stria terminalis, or BNST.
The BNST sits near the amygdala but handles a distinct job. While the amygdala manages phasic fear (quick, cue-based reactions), the BNST mediates the slow-burn, hard-to-pin-down dread that characterizes clinical anxiety. It activates during uncertain or unpredictable threats and stays active long after the amygdala would have quieted down. This is the region most responsible for that “something bad is going to happen” feeling that has no clear source.
Chemical Imbalances That Shift the Balance
The circuits described above run on chemical messengers, and the balance between two of them is central to anxiety. GABA is the brain’s primary calming chemical. It works by dampening neural activity, preventing neurons from firing too easily. Glutamate does the opposite: it excites neurons and ramps up signaling. A healthy brain keeps these two in tight equilibrium.
In the amygdala specifically, networks of GABA-releasing neurons act as a braking system. They sit between different sections of the amygdala and control how much excitatory signal gets through to the output regions that trigger fear behavior. When GABA production drops or these inhibitory networks malfunction, excitatory glutamate signals pass through unchecked, and the amygdala’s threat response amplifies. This is why medications that boost GABA activity (like benzodiazepines) can reduce anxiety so quickly, and why conditions that impair GABA production tend to increase it.
Two other chemical systems play important roles. Serotonin, produced in a brainstem region called the dorsal raphe, modulates stress and anxiety across multiple brain areas including the amygdala and prefrontal cortex. Stress increases serotonin release and turnover in these regions, and disruptions in serotonin signaling are a well-established feature of anxiety disorders. Norepinephrine, produced in a nearby brainstem cluster called the locus coeruleus, drives the hyperarousal symptoms many anxious people experience: the racing heart, the heightened startle response, the feeling of being constantly on edge. Abnormal regulation of norepinephrine pathways projecting to the amygdala, hippocampus, and prefrontal cortex is consistently observed in anxiety and PTSD.
How Stress Hormones Reshape the Brain
Short-term stress is something your brain handles well. Chronic stress is a different matter. When stress persists for weeks or months, the body’s stress hormone system (the hypothalamic-pituitary-adrenal axis, or HPA axis) stays activated, flooding the brain with cortisol. Over time, elevated cortisol damages vulnerable brain structures.
The hippocampus, a region critical for memory and context, is especially susceptible. Chronic cortisol exposure can cause hippocampal atrophy, meaning the tissue physically shrinks. This matters for anxiety because the hippocampus helps you distinguish between a genuinely dangerous situation and a safe one that merely resembles something scary. With a smaller, less functional hippocampus, your brain has a harder time making that distinction, which feeds the cycle of inappropriate fear responses. Studies have found that smaller hippocampal volume is associated with greater anxiety symptoms, and preliminary evidence suggests that reduced hippocampal size may actually precede anxiety rather than result from it, acting as a vulnerability factor.
Cortisol also impairs the prefrontal cortex and limbic structures, weakening the very regions responsible for keeping the amygdala in check. This creates a vicious loop: stress weakens prefrontal control, which allows the amygdala to dominate, which generates more anxiety, which produces more cortisol.
What Brain Scans Reveal
Functional brain imaging of people with generalized anxiety disorder shows a consistent pattern. The amygdala, insula (a region involved in body awareness and emotional processing), thalamus, and a core region of the default mode network called the posterior cingulate cortex all show stronger-than-normal connectivity with each other. Meanwhile, the frontal and temporal cortex regions, areas associated with reasoning and emotional regulation, show weaker connectivity.
The increased activity in the default mode network is particularly telling. This network is most active during inward-focused thought: daydreaming, self-reflection, and, critically, worry. Heightened connectivity within this network correlates directly with anxiety and depression scores, which aligns with the subjective experience of anxiety as an inability to stop ruminating.
Genetics and Epigenetics
Anxiety runs in families, but the genetics are complex. Heritability estimates for anxiety disorders sit around 41%, meaning that roughly four-tenths of the variation in anxiety risk across a population can be attributed to genetic differences. (When anxiety co-occurs with depression, heritability jumps to about 79%.) No single gene causes anxiety. Instead, thousands of small genetic variations each contribute a tiny amount of risk. Current genetic risk scores can only explain about 0.5 to 2.3% of the variation in who develops an anxiety disorder, highlighting how much of the picture is still missing.
What’s increasingly clear is that the environment can change how anxiety-related genes behave without altering the DNA sequence itself. This is epigenetics. Prenatal stress offers a striking example: when pregnant animals are exposed to chronic restraint stress, their offspring show anxiety-like behavior paired with specific chemical modifications to genes controlling the stress hormone system. These modifications, particularly changes in DNA methylation, alter how actively certain genes are read. In one line of research, stressed offspring showed reduced methylation of genes involved in cortisol receptor signaling in the hypothalamus, essentially keeping their stress response system on a hair trigger. Remarkably, some of these epigenetic changes initiated in the womb persisted into adulthood.
Other studies have traced a more direct path. Environmental exposures that increase DNA methylation in the amygdala can suppress production of the enzyme that converts glutamate into GABA. Less of that enzyme means less GABA, more unchecked excitatory signaling, and more anxiety. When researchers reversed the methylation with a targeted drug, both the enzyme levels and the anxiety behavior normalized.
Inflammation as a Brain Signal
A growing body of evidence connects immune system activity to anxiety. When your body mounts an inflammatory response, whether from infection, chronic illness, or psychological stress, it releases signaling molecules called cytokines into the bloodstream. These immune signals can influence brain function, altering mood and fueling anxiety. One leading theory is that chronic inflammation gradually weakens the blood-brain barrier, the protective layer that normally keeps bloodborne substances out of the brain, making it more permeable to inflammatory molecules. Once inside, these signals can disrupt the same neurotransmitter systems and brain circuits involved in anxiety regulation.
This connection has opened up new thinking about treatment approaches. Rather than targeting brain chemistry directly with drugs that must cross the blood-brain barrier, some researchers are exploring whether adjusting immune signals from outside the brain could reduce anxiety symptoms. The exact mechanisms are still being mapped, but the link between body-wide inflammation and brain-based anxiety is now well established enough that it has shifted how scientists think about anxiety as a whole: not purely a brain disorder, but one that involves communication between the immune system and the nervous system.